The primary objectives of this study were to evaluate the effect of food on the oral bioavailability and to evaluate the effect of diurnal variation on the pharmacokinetics of linifanib , a novel tyrosine kinase ( TK ) inhibitor selective for vascular endothelial growth factor ( VEGF ) and platelet-derived growth factor ( PDGF ) receptors , in patients with advanced solid tumors .